REPORT ID 3183

Global Blood-Brain Barrier Transport Drugs Market Professional Survey Report 2017

Publish Date
12-Dec-17
Pages
118
Format
Electronic (PDF)

This report studies Blood-Brain Barrier Transport Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Cyclenium
    BioAdvance
    EIP Pharma
    Bioasis
    Immune Pharmaceuticals
    AZ Therapies
    Palobiofarma
    Bach Pharma
    BrainsGate
    CarThera
    Dainippon Sumitomo Pharma
    Fluorinov Pharma
    Fondazione Telethon
    Minoryx
    NewGen Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Carrier-mediated Transport
    Receptor-mediated Transport
    Absorptive-mediated Transport
    Active Efflux Transport
    Others

By Application, the market can be split into
    Alzheimer's Disease
    Epilepsy
    Parkinson's Disease
    Multiple Sclerosis
    Hunter's Syndrome
    Brain Cancer
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Blood-Brain Barrier Transport Drugs Market Professional Survey Report 2017
1 Industry Overview of Blood-Brain Barrier Transport Drugs
    1.1 Definition and Specifications of Blood-Brain Barrier Transport Drugs
        1.1.1 Definition of Blood-Brain Barrier Transport Drugs
        1.1.2 Specifications of Blood-Brain Barrier Transport Drugs
    1.2 Classification of Blood-Brain Barrier Transport Drugs
        1.2.1 Carrier-mediated Transport
        1.2.2 Receptor-mediated Transport
        1.2.3 Absorptive-mediated Transport
        1.2.4 Active Efflux Transport
        1.2.5 Others
    1.3 Applications of Blood-Brain Barrier Transport Drugs
        1.3.1 Alzheimer's Disease
        1.3.2 Epilepsy
        1.3.3 Parkinson's Disease
        1.3.4 Multiple Sclerosis
        1.3.5 Hunter's Syndrome
        1.3.6 Brain Cancer
        1.3.7 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs
    2.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
    2.4 Industry Chain Structure of Blood-Brain Barrier Transport Drugs

3 Technical Data and Manufacturing Plants Analysis of Blood-Brain Barrier Transport Drugs
    3.1 Capacity and Commercial Production Date of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016

4 Global Blood-Brain Barrier Transport Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Blood-Brain Barrier Transport Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Blood-Brain Barrier Transport Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Blood-Brain Barrier Transport Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Blood-Brain Barrier Transport Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Blood-Brain Barrier Transport Drugs Sales Price
        4.4.2 2016 Blood-Brain Barrier Transport Drugs Sales Price Analysis (Company Segment)

5 Blood-Brain Barrier Transport Drugs Regional Market Analysis
    5.1 North America Blood-Brain Barrier Transport Drugs Market Analysis
        5.1.1 North America Blood-Brain Barrier Transport Drugs Market Overview
        5.1.2 North America 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
        5.1.4 North America 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
    5.2 China Blood-Brain Barrier Transport Drugs Market Analysis
        5.2.1 China Blood-Brain Barrier Transport Drugs Market Overview
        5.2.2 China 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
        5.2.4 China 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
    5.3 Europe Blood-Brain Barrier Transport Drugs Market Analysis
        5.3.1 Europe Blood-Brain Barrier Transport Drugs Market Overview
        5.3.2 Europe 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
        5.3.4 Europe 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
    5.4 Southeast Asia Blood-Brain Barrier Transport Drugs Market Analysis
        5.4.1 Southeast Asia Blood-Brain Barrier Transport Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
    5.5 Japan Blood-Brain Barrier Transport Drugs Market Analysis
        5.5.1 Japan Blood-Brain Barrier Transport Drugs Market Overview
        5.5.2 Japan 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
        5.5.4 Japan 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis
    5.6 India Blood-Brain Barrier Transport Drugs Market Analysis
        5.6.1 India Blood-Brain Barrier Transport Drugs Market Overview
        5.6.2 India 2012-2017E Blood-Brain Barrier Transport Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Blood-Brain Barrier Transport Drugs Sales Price Analysis
        5.6.4 India 2016 Blood-Brain Barrier Transport Drugs Market Share Analysis

6 Global 2012-2017E Blood-Brain Barrier Transport Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Blood-Brain Barrier Transport Drugs Sales by Type
    6.2 Different Types of Blood-Brain Barrier Transport Drugs Product Interview Price Analysis
    6.3 Different Types of Blood-Brain Barrier Transport Drugs Product Driving Factors Analysis
        6.3.1 Carrier-mediated Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        6.3.2 Receptor-mediated Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        6.3.3 Absorptive-mediated Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        6.3.4 Active Efflux Transport of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        6.3.5 Others of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Blood-Brain Barrier Transport Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Blood-Brain Barrier Transport Drugs Consumption by Application
    7.2 Different Application of Blood-Brain Barrier Transport Drugs Product Interview Price Analysis
    7.3 Different Application of Blood-Brain Barrier Transport Drugs Product Driving Factors Analysis
        7.3.1 Alzheimer's Disease of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        7.3.2 Epilepsy of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        7.3.3 Parkinson's Disease of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        7.3.4 Multiple Sclerosis of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        7.3.5 Hunter's Syndrome of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        7.3.6 Brain Cancer of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis
        7.3.7 Others of Blood-Brain Barrier Transport Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Blood-Brain Barrier Transport Drugs
    8.1 Cyclenium
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Cyclenium 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Cyclenium 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.2 BioAdvance
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 BioAdvance 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 BioAdvance 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.3 EIP Pharma
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 EIP Pharma 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 EIP Pharma 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.4 Bioasis
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Bioasis 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Bioasis 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.5 Immune Pharmaceuticals
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Immune Pharmaceuticals 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Immune Pharmaceuticals 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.6 AZ Therapies
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 AZ Therapies 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 AZ Therapies 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.7 Palobiofarma
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Palobiofarma 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Palobiofarma 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.8 Bach Pharma
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Bach Pharma 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Bach Pharma 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.9 BrainsGate
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 BrainsGate 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 BrainsGate 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.10 CarThera
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 CarThera 2016 Blood-Brain Barrier Transport Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 CarThera 2016 Blood-Brain Barrier Transport Drugs Business Region Distribution Analysis
    8.11 Dainippon Sumitomo Pharma
    8.12 Fluorinov Pharma
    8.13 Fondazione Telethon
    8.14 Minoryx
    8.15 NewGen Therapeutics

9 Development Trend of Analysis of Blood-Brain Barrier Transport Drugs Market
    9.1 Global Blood-Brain Barrier Transport Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Blood-Brain Barrier Transport Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Blood-Brain Barrier Transport Drugs Sales Price Forecast
    9.2 Blood-Brain Barrier Transport Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
        9.2.2 China 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
        9.2.6 India 2017-2022 Blood-Brain Barrier Transport Drugs Consumption Forecast
    9.3 Blood-Brain Barrier Transport Drugs Market Trend (Product Type)
    9.4 Blood-Brain Barrier Transport Drugs Market Trend (Application)

10 Blood-Brain Barrier Transport Drugs Marketing Type Analysis
    10.1 Blood-Brain Barrier Transport Drugs Regional Marketing Type Analysis
    10.2 Blood-Brain Barrier Transport Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Blood-Brain Barrier Transport Drugs by Region
    10.4 Blood-Brain Barrier Transport Drugs Supply Chain Analysis

11 Consumers Analysis of Blood-Brain Barrier Transport Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Blood-Brain Barrier Transport Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source